Trial intelligence / Profile preview

Bextra vs Naproxen in Severe Rheumatoid Arthritis

NCT00650455Phase 4Completed

Sponsor
Pfizer
Start
Feb 2003
Primary completion
Jan 2005
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of valdecoxib in rheumatoid arthritis (RA), sponsored by Pfizer. Started Feb 2003; status: completed.

02

Drugs

valdecoxib
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00650455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00650455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call